FDA Clears Way for ClearRead CT Software

The first FDA cleared device demonstrating superior nodule detection performance and faster reading using a concurrent read DAYTON, Ohio–(BUSINESS WIRE)–Riverain Technologies is committed to providing cutting edge software to aid the clinician in the efficient, effective early detection of lung disease. Today, Riverain Technologies announces ClearRead CT, a breakthrough nodule detection application, has received clearance from the Food and Drug Administration (FDA). ClearRead CT is the only FDA cleared device to support concurrent reading, allowing for faster reading with proven superior automatic nodule detection performance for all primary nodule types, including: solid, sub-solid and ground glass nodules. ClearRead CT, powered by acquisition normalization technology, provides an enterprise ready solution for the entire healthcare network. The technology seamlessly processes CT scans from a wide range of manufacturers and acquisition protocols and…

Link to Full Article: FDA Clears Way for ClearRead CT Software

Pin It on Pinterest

Share This